Disease Overview：Cerebral infarction（CI）
Cerebral infarction—commonly referred to as ischemic stroke—is a leading cause of mortality and long-term disability worldwide. It occurs when cerebral blood flow is abruptly interrupted due to thrombosis or embolism, resulting in neuronal necrosis within the affected vascular territory. Clinical presentation varies by lesion location and size but often includes sudden-onset hemiparesis, aphasia, visual field deficits, ataxia, or altered consciousness. Prompt diagnosis via non-contrast CT or MRI diffusion-weighted imaging is critical; acute management hinges on intravenous thrombolysis (e.g., alteplase) within 3–4.5 hours or mechanical thrombectomy for large-vessel occlusion up to 24 hours in selected cases. Secondary prevention emphasizes antithrombotic therapy, blood pressure and lipid control, glycemic management, and lifestyle modification. Long-term rehabilitation—including physical, occupational, and speech therapy—is integral to functional recovery.
China offers distinct advantages for international patients seeking high-quality, evidence-based care for cerebral infarction. The country’s top-tier neurology centers—many affiliated with Peking University Health Science Center, Fudan University Shanghai Medical College, and Sun Yat-sen University—employ internationally trained neurologists and stroke specialists certified by the Chinese Stroke Prevention and Treatment Guidelines and aligned with AHA/ASA standards. Advanced neurointerventional suites equipped with biplane angiography systems, AI-assisted perfusion imaging, and real-time intraoperative neuromonitoring support precision thrombectomy and individualized reperfusion strategies. Clinical outcomes reflect this capability: national stroke registries report median door-to-needle times under 30 minutes and 90-day modified Rankin Scale scores comparable to Western benchmarks. Crucially, treatment costs—including diagnostics, acute intervention, and multidisciplinary rehabilitation—are typically 40–60% lower than in the US, UK, or Germany, without compromising safety or efficacy.
As a dedicated medical tourism agency, we facilitate seamless access to these resources for international patients. We coordinate hospital referrals with accredited tertiary stroke centers, provide itemized, transparent pricing in advance, assist with visa documentation and travel logistics, and assign bilingual care coordinators to oversee every stage—from pre-admission evaluation through post-discharge follow-up. Our partnerships ensure continuity of care, timely appointments, and culturally sensitive support—helping patients prioritize clinical outcomes while navigating cross-border healthcare with confidence.
Cerebral infarction: treatment in China helps patients compare specialist hospitals, initial assessment steps and estimated costs that may vary by city, institution and clinical condition.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Ischemic Stroke (Cerebral Infarction)
Non-Surgical / Conservative Management
*Target criteria:* Acute phase (<24–72 hrs), mild-to-moderate NIHSS ≤12, no large vessel occlusion on CTA/MRA, stable vitals, no contraindications to antithrombotics.
- •Acute Thrombolysis (IV rt-PA)
- Drug cost (alteplase): $420–$580 - Pre-treatment labs (CBC, PT/INR, glucose, creatinine): $45 - Neuroimaging (non-contrast CT + CTA): $180–$260 - ICU monitoring (24-hr): $320–$450
- •Antiplatelet Therapy (Dual – Aspirin + Clopidogrel)
- Long-term monotherapy (aspirin or clopidogrel): $8–$12/month - Lipid-lowering (high-intensity statin, e.g., atorvastatin 40 mg): $10–$15/month - BP control (amlodipine + perindopril combo): $12–$20/month
- •Rehabilitation & Monitoring
- Outpatient follow-up (neurology consult + EEG/EEG + repeat MRI at 3 mo): $290–$410
Surgical / Interventional Procedures
*Eligibility:* Confirmed large-vessel occlusion (ICA, MCA, basilar) on CTA/MRA; onset ≤6 hrs (up to 24 hrs with perfusion mismatch); NIHSS ≥6; no significant early ischemic changes on CT.
- •Mechanical Thrombectomy (MT)
- Pre-op workup (CTP + CTA + coagulation panel + ECG + chest X-ray): $220–$310 - Post-op ICU stay (48–72 hrs): $680–$950 - Device-specific add-ons (e.g., balloon guide catheter): +$320–$460
Special / Complex Condition Management
- •Basilar Artery Occlusion (BAO): Extended window MT + intra-arterial thrombolysis — $7,100–$8,900
- •Cardioembolic Stroke (AF-related): DOAC initiation (apixaban/rivaroxaban) + transesophageal echo (TEE) — $1,050–$1,350 (TEE: $280; DOAC 3-mo supply: $190)
- •Recurrent Stroke Prevention (≥2 events): Carotid endarterectomy (CEA) — $5,400–$6,700, including pre-op Doppler ($110) and post-op duplex ($95)
Quick Selection Guide
- •<60 years, NIHSS ≤5, no comorbidities: IV rt-PA + outpatient rehab ($1,200–$1,800)
- •60–75 years, NIHSS 8–15, confirmed MCA occlusion: Mechanical thrombectomy ($6,000–$7,500)
- •>75 years, multiple comorbidities (CKD, HF), NIHSS ≤10: Conservative antiplatelet + statin + rehab ($1,400–$2,200)
- •Budget-constrained (<$1,000): Aspirin + statin + BP meds + community-based rehab ($320–$580)
- •Recurrent embolic stroke + AF: DOAC + TEE-guided management ($1,100–$1,400)
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Cerebral infarction Medical Vacation Packages
Curated transparent all-inclusive packages combining Cerebral infarction treatment with China top medical destinations:
